GlassScriptPhysician profile
Adel W Mohamed
NPI 1750425195
$4,823.44
in general payments reported to CMS, 2019-2025
26 companies · $368 in 2025
The $368 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,213 · 2020: $307 · 2021: $410 · 2022: $442 · 2023: $331 · 2024: $1,752 · 2025: $368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Food and Beverage: $951.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Food and Beverage | $950.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,500.00 | 2024 | |
| Boston Scientific Corporation | $916.37 | 2019-2021 | |
| Astellas Pharma US INC | $556.99 | 2019-2025 | Xtandi |
| Janssen Biotech, INC. | $401.93 | 2019-2023 | Erleada |
| Pfizer INC. | $255.06 | 2019-2025 | |
| Allergan, INC. | $159.17 | 2019-2022 | |
| Abbvie INC. | $152.54 | 2020-2025 | |
| Tolmar, INC. | $110.24 | 2023-2025 | Eligard, Jatenzo |
| Sumitomo Pharma America, INC. | $103.15 | 2023-2025 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $96.64 | 2024-2025 | |
| Urovant Sciences INC | $78.33 | 2022 | |
| Medtronic, INC. | $61.45 | 2025 | Interstim |
| Endo Pharmaceuticals INC. | $59.21 | 2019-2024 | Xiaflex, Aveed |
| Merck Sharp & Dohme LLC | $38.63 | 2023 | Keytruda |
| Myovant Sciences INC. | $35.75 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abc Home Medical Supply, INC. | $34.76 | 2025 | |
| Cycle Pharmaceuticals INC | $33.64 | 2025 | Venxxiva |
| Acerus Pharmaceuticals Corporation | $32.45 | 2022 | |
| Coloplast Corp | $31.94 | 2019-2022 | |
| Laborie Medical Technologies Corp. | $29.31 | 2023 | |
| Olympus America INC. | $27.02 | 2023 | Hysteroflow II, Itind System |
| Teleflex LLC | $26.35 | 2022 | |
| Novartis Pharmaceuticals Corporation | $24.31 | 2023 | |
| Endo USA, INC. | $24.06 | 2024 | Aveed, Xiaflex |
| Rgh Enterprises LLC | $17.60 | 2019 | |
| Urogen Pharma, INC. | $16.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adel Mohamed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.